These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Cholinesterase inhibitors for vascular dementia and other vascular cognitive impairments: a network meta-analysis. Battle CE; Abdul-Rahim AH; Shenkin SD; Hewitt J; Quinn TJ Cochrane Database Syst Rev; 2021 Feb; 2(2):CD013306. PubMed ID: 33704781 [TBL] [Abstract][Full Text] [Related]
5. Withdrawal or continuation of cholinesterase inhibitors or memantine or both, in people with dementia. Parsons C; Lim WY; Loy C; McGuinness B; Passmore P; Ward SA; Hughes C Cochrane Database Syst Rev; 2021 Feb; 2(2):CD009081. PubMed ID: 35608903 [TBL] [Abstract][Full Text] [Related]
6. Clinical and cost-effectiveness of donepezil, rivastigmine and galantamine for Alzheimer's disease: a rapid and systematic review. Clegg A; Bryant J; Nicholson T; McIntyre L; De Broe S; Gerard K; Waugh N Health Technol Assess; 2001; 5(1):1-137. PubMed ID: 11262420 [TBL] [Abstract][Full Text] [Related]
7. Pharmacological treatment for memory disorder in multiple sclerosis. He D; Zhang Y; Dong S; Wang D; Gao X; Zhou H Cochrane Database Syst Rev; 2013 Dec; (12):CD008876. PubMed ID: 24343792 [TBL] [Abstract][Full Text] [Related]
8. Interventions for preventing and ameliorating cognitive deficits in adults treated with cranial irradiation. Day J; Zienius K; Gehring K; Grosshans D; Taphoorn M; Grant R; Li J; Brown PD Cochrane Database Syst Rev; 2014 Dec; 2014(12):CD011335. PubMed ID: 25519950 [TBL] [Abstract][Full Text] [Related]
9. Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease. Rolinski M; Fox C; Maidment I; McShane R Cochrane Database Syst Rev; 2012 Mar; 2012(3):CD006504. PubMed ID: 22419314 [TBL] [Abstract][Full Text] [Related]
18. The effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease (review of Technology Appraisal No. 111): a systematic review and economic model. Bond M; Rogers G; Peters J; Anderson R; Hoyle M; Miners A; Moxham T; Davis S; Thokala P; Wailoo A; Jeffreys M; Hyde C Health Technol Assess; 2012; 16(21):1-470. PubMed ID: 22541366 [TBL] [Abstract][Full Text] [Related]
19. The clinical and cost-effectiveness of donepezil, rivastigmine, galantamine and memantine for Alzheimer's disease. Loveman E; Green C; Kirby J; Takeda A; Picot J; Payne E; Clegg A Health Technol Assess; 2006 Jan; 10(1):iii-iv, ix-xi, 1-160. PubMed ID: 16409879 [TBL] [Abstract][Full Text] [Related]